JAFKX Holdings — Health Sciences Trust
All 173 reported holdings of Health Sciences Trust (JAFKX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly and Company | 14.30% | $35.94M |
| Johnson and Johnson | 6.33% | $15.90M |
| UnitedHealth Group Incorporated | 5.95% | $14.95M |
| AbbVie Inc. | 5.28% | $13.28M |
| Merck and Co. Inc. | 4.21% | $10.59M |
| Gilead Sciences Inc. | 2.95% | $7.41M |
| Thermo Fisher Scientific Inc. | 2.67% | $6.70M |
| Vertex Pharmaceuticals Incorporated | 2.38% | $5.97M |
| Bristol-Myers Squibb Company | 2.22% | $5.58M |
| Abbott Laboratories | 2.00% | $5.03M |
| Intuitive Surgical Inc. | 1.98% | $4.98M |
| Amgen Inc. | 1.90% | $4.78M |
| Stryker Corporation | 1.87% | $4.71M |
| Elevance Health Inc. | 1.63% | $4.09M |
| Danaher Corporation | 1.51% | $3.79M |
| Natera Inc. | 1.49% | $3.75M |
| Guardant Health Inc. | 1.28% | $3.23M |
| Cardinal Health Inc. | 1.09% | $2.74M |
| Royalty Pharma plc | 1.02% | $2.56M |
| Tenet Healthcare Corporation | 0.99% | $2.50M |
| CVS Health Corporation | 0.98% | $2.46M |
| Kymera Therapeutics Inc. | 0.93% | $2.35M |
| Protagonist Therapeutics Inc. | 0.90% | $2.25M |
| BrightSpring Health Services Inc. | 0.88% | $2.21M |
| Moderna Inc. | 0.87% | $2.19M |
| Revolution Medicines Inc. | 0.82% | $2.06M |
| Roivant Sciences Ltd. | 0.75% | $1.88M |
| Alnylam Pharmaceuticals Inc. | 0.72% | $1.82M |
| Rowe T Price Gov Res Fd 20340919 00000.0000000000 | 0.70% | $1.76M |
| Viatris Inc. | 0.68% | $1.72M |
| Charles River Laboratories International Inc. | 0.66% | $1.65M |
| argenx SE | 0.63% | $1.57M |
| Edwards Lifesciences Corporation | 0.62% | $1.56M |
| Centene Corporation | 0.61% | $1.53M |
| Spyre Therapeutics Inc. | 0.57% | $1.43M |
| Definium Therapeutics Inc. | 0.53% | $1.34M |
| Mirum Pharmaceuticals Inc. | 0.52% | $1.30M |
| Insmed Incorporated | 0.51% | $1.29M |
| Chugai Pharmaceutical Co. Ltd. | 0.51% | $1.27M |
| Twist Bioscience Corporation | 0.50% | $1.27M |
| AstraZeneca PLC | 0.49% | $1.22M |
| Boston Scientific Corporation | 0.48% | $1.19M |
| United Therapeutics Corporation | 0.46% | $1.16M |
| Medtronic Public Limited Company | 0.46% | $1.15M |
| Krystal Biotech Inc. | 0.45% | $1.13M |
| Erasca Inc. | 0.42% | $1.05M |
| Praxis Precision Medicines Inc. | 0.41% | $1.03M |
| Ascendis Pharma A/S | 0.41% | $1.02M |
| BillionToOne Inc. | 0.41% | $1.02M |
| Medpace Holdings Inc. | 0.39% | $985.57K |
| Tango Therapeutics Inc | 0.39% | $969.87K |
| Monte Rosa Therapeutics Inc. | 0.38% | $964.76K |
| Scholar Rock Holding Corporation | 0.38% | $949.30K |
| Oruka Therapeutics Inc. | 0.38% | $944.09K |
| Humana Inc. | 0.37% | $937.44K |
| BeOne Medicines Ltd | 0.37% | $932.82K |
| Dianthus Therapeutics Inc. | 0.37% | $918.36K |
| Kodiak Sciences Inc. | 0.35% | $873.25K |
| Summit Therapeutics Inc. | 0.32% | $815.98K |
| Novo Nordisk A/S | 0.32% | $795.66K |
| Vera Therapeutics Inc. | 0.31% | $775.73K |
| Axsome Therapeutics Inc. | 0.31% | $774.94K |
| CG Oncology Inc. | 0.31% | $767.70K |
| Ionis Pharmaceuticals Inc. | 0.30% | $765.07K |
| Regeneron Pharmaceuticals Inc. | 0.30% | $756.98K |
| Cytokinetics Incorporated | 0.30% | $744.56K |
| Agilent Technologies Inc. | 0.29% | $730.57K |
| Kailera Therapeutics Inc. | 0.29% | $728.51K |
| Enliven Therapeutics Inc. | 0.29% | $722.73K |
| MBX Biosciences Inc. | 0.28% | $714.45K |
| Relay Therapeutics Inc. | 0.28% | $710.31K |
| NewAmsterdam Pharma Company N.V. | 0.27% | $684.58K |
| Waters Corporation | 0.27% | $675.07K |
| Madrigal Pharmaceuticals Inc. | 0.27% | $671.19K |
| Crinetics Pharmaceuticals Inc. | 0.27% | $670.90K |
| BridgeBio Pharma Inc. | 0.26% | $647.60K |
| Nurix Therapeutics Inc. | 0.26% | $647.33K |
| Rhythm Pharmaceuticals Inc. | 0.26% | $646.75K |
| Liquidia Corporation | 0.26% | $646.69K |
| West Pharmaceutical Services Inc. | 0.26% | $646.20K |
| Beam Therapeutics Inc. | 0.26% | $643.43K |
| IDEAYA Biosciences Inc. | 0.24% | $596.99K |
| Teva Pharmaceutical Industries Limited | 0.24% | $596.29K |
| Viridian Therapeutics Inc. | 0.23% | $589.07K |
| Alkermes Public Limited Company | 0.23% | $586.82K |
| Alignment Healthcare Inc. | 0.23% | $576.06K |
| Vaxcyte Inc. | 0.22% | $540.49K |
| Immunome Inc. | 0.20% | $510.40K |
| Rapport Therapeutics Inc. | 0.20% | $493.16K |
| Structure Therapeutics Inc. | 0.20% | $490.60K |
| Palvella Therapeutics Inc. | 0.19% | $484.90K |
| State Street Bank and Trust Company | 0.19% | $482.17K |
| Climb Bio Inc. | 0.19% | $470.74K |
| Icon Public Limited Company | 0.19% | $469.02K |
| Seaport Therapeutics Inc. | 0.18% | $456.66K |
| Celldex Therapeutics Inc. | 0.18% | $449.98K |
| Cencora Inc. | 0.17% | $425.60K |
| Immunocore Holdings plc | 0.17% | $422.31K |
| ORIC Pharmaceuticals Inc. | 0.17% | $417.08K |
| Sonova Holding AG | 0.16% | $399.69K |
| Encompass Health Corporation | 0.16% | $398.36K |
| Abivax SA | 0.15% | $375.26K |
| Alumis Inc. | 0.15% | $371.67K |
| Apogee Therapeutics Inc. | 0.14% | $364.21K |
| Veeva Systems Inc. | 0.14% | $354.94K |
| Bicara Therapeutics Inc. | 0.14% | $354.85K |
| Cogent Biosciences Inc. | 0.13% | $336.07K |
| MoonLake Immunotherapeutics | 0.13% | $335.55K |
| Generate Biomedicines Inc. | 0.13% | $325.20K |
| Ocular Therapeutix Inc. | 0.12% | $311.29K |
| Stoke Therapeutics Inc. | 0.12% | $304.30K |
| Incyte Corporation | 0.12% | $301.88K |
| Arrowhead Pharmaceuticals Inc. | 0.12% | $301.02K |
| Immix Biopharma Inc. | 0.11% | $288.60K |
| Parabilis Medicines Inc. | 0.11% | $277.29K |
| Belite Bio Inc | 0.11% | $277.17K |
| Cullinan Therapeutics Inc. | 0.11% | $276.79K |
| Sionna Therapeutics Inc. | 0.11% | $275.91K |
| Shattuck Labs Inc. | 0.11% | $275.86K |
| Biohaven Ltd. | 0.11% | $275.50K |
| Avalyn Pharma Inc. | 0.11% | $269.98K |
| BioNTech SE | 0.10% | $260.54K |
| Immunocore Holdings plc | 0.10% | $253.46K |
| Denali Therapeutics Inc. | 0.10% | $244.65K |
| Tyra Biosciences Inc. | 0.10% | $239.55K |
| Quest Diagnostics Incorporated | 0.09% | $233.15K |
| Tarsus Pharmaceuticals Inc. | 0.09% | $232.19K |
| Pharvaris N.V. | 0.09% | $230.58K |
| Disc Medicine Inc. | 0.09% | $222.86K |
| Aktis Oncology Inc. | 0.09% | $219.45K |
| Xencor Inc. | 0.08% | $212.18K |
| Atrium Therapeutics Inc. | 0.08% | $200.41K |
| Avalo Therapeutics Inc. | 0.08% | $190.49K |
| Nanobiotix S.A. | 0.07% | $185.63K |
| Corvus Pharmaceuticals Inc. | 0.07% | $182.73K |
| Procept Biorobotics Corporation | 0.07% | $180.37K |
| Wave Life Sciences Ltd. | 0.07% | $174.20K |
| IQVIA Holdings Inc. | 0.07% | $172.16K |
| Hemab Therapeutics Holdings Inc. | 0.06% | $157.39K |
| Kyverna Therapeutics Inc. | 0.06% | $156.09K |
| Alto Neuroscience Inc. | 0.06% | $155.70K |
| Odyssey Therapeutics Inc. | 0.06% | $147.79K |
| Agios Pharmaceuticals Inc. | 0.06% | $147.33K |
| Allogene Therapeutics Inc. | 0.06% | $146.21K |
| Olema Pharmaceuticals Inc. | 0.06% | $142.75K |
| Tenax Therapeutics Inc. | 0.06% | $141.47K |
| Adaptive Biotechnologies Corporation | 0.06% | $138.50K |
| SpyGlass Pharma Inc. | 0.05% | $133.38K |
| Celcuity Inc. | 0.05% | $132.34K |
| Inspire Medical Systems Inc. | 0.05% | $124.91K |
| Immatics N.V. | 0.05% | $118.52K |
| Cabaletta Bio Inc. | 0.05% | $115.69K |
| Evommune Inc. | 0.04% | $108.99K |
| Bicycle Therapeutics plc | 0.04% | $108.55K |
| Crescent Biopharma Inc. | 0.04% | $107.26K |
| Iovance Biotherapeutics Inc. | 0.04% | $106.35K |
| Eikon Therapeutics Inc. | 0.04% | $94.10K |
| Entrada Therapeutics Inc. | 0.03% | $85.69K |
| Xenon Pharmaceuticals Inc. | 0.03% | $78.47K |
| BioMarin Pharmaceutical Inc. | 0.03% | $74.39K |
| Sensorion | 0.03% | $73.59K |
| GE HealthCare Technologies Inc. | 0.03% | $64.01K |
| Immuneering Corporation | 0.02% | $59.86K |
| Dyne Therapeutics Inc. | 0.02% | $55.52K |
| BridgeBio Oncology Therapeutics Inc. | 0.02% | $55.34K |
| Caris Life Sciences Inc. | 0.02% | $52.82K |
| Revolution Medicines Inc. | 0.02% | $42.32K |
| Aura Biosciences Inc. | 0.01% | $36.54K |
| MapLight Therapeutics Inc. | 0.01% | $33.30K |
| Tectonic Therapeutic Inc. | 0.01% | $25.99K |
| Contra Generation Bio Common Stock | 0.00% | $3.95K |
| SomaLogic Inc. | 0.00% | $0 |
| GeneDx Holdings Corp. | 0.00% | $14 |
JAFKX overview: performance, fees, allocation and SEC filings